My papers make important contributions to the field, are well-cited, attract expert commentary and find wide media coverage.
According to Scopus and Dimensions, my papers have accumulated over 125 citations by nearly 100 papers. My orexin work is currently my most cited work, with multiple papers on the topic having accumulated over a dozen citations.Four of my papers have accumulated over a dozen citations each.
Many of my experiments in the orexin system returned null results, providing a rare voice of caution in the addiction and orexin literature. These results have been cited by review articles on potential clinical uses of orexin antagonists, which helps to protect human participants from overly optimistic clinical trials.
Recent publications have also shown early signs of strong academic impact. For example, my 2019 Neuropsychopharmacology paper on the interaction between context and neuroanatomic topography in the basolateral amygdala attracted a research highlight commentary in the journal.
Media, Policy and Educational Impact
My 2019 LIBER Quarterly article on open access article processing charge hyperinflation and author price insensitivity has been shared widely on social media, been cited by policy documents and in articles by influential people in scholarly publishing, like the CEO of PLOS. As a result, its Altmetric score is in the top 0.5% of all research outputs tracked by Altmetric.
My addiction neuroscience work has been communicated to the public to illustrate preclinical drug development, how addictive psychological processes are studied in animal models and to discuss similarities between food and drug addiction. These articles are frequently circulated to school-age children and general interest audiences. For example, my Frontiers for Young Minds article on psychological processes and animal models actively involved children aged 13-16 in its review process, helping young people to learn about the scientific peer review process as well as Pavlovian conditioning and addiction research.